Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$41.76 - $74.73 $4.15 Million - $7.42 Million
-99,292 Reduced 73.21%
36,330 $1.74 Million
Q4 2023

Feb 14, 2024

BUY
$58.16 - $75.44 $15,819 - $20,519
272 Added 0.2%
135,622 $10 Million
Q3 2023

Nov 14, 2023

SELL
$70.9 - $88.63 $33,181 - $41,478
-468 Reduced 0.34%
135,350 $9.89 Million
Q2 2023

Aug 14, 2023

BUY
$81.09 - $94.16 $789,248 - $916,459
9,733 Added 7.72%
135,818 $11.3 Million
Q1 2023

May 15, 2023

BUY
$82.98 - $91.46 $3.28 Million - $3.62 Million
39,544 Added 45.69%
126,085 $11.2 Million
Q4 2022

Feb 21, 2023

SELL
$66.93 - $97.5 $268,456 - $391,072
-4,011 Reduced 4.43%
86,541 $7.41 Million
Q3 2022

Nov 14, 2022

BUY
$69.86 - $107.63 $292,573 - $450,754
4,188 Added 4.85%
90,552 $6.5 Million
Q2 2022

Aug 15, 2022

BUY
$89.06 - $117.64 $7.69 Million - $10.2 Million
86,364 New
86,364 $8.39 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.69B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.